Orion Corp (NASDAQ:ORINY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company’s core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland. “

Shares of Orion Corp (ORINY) opened at 31.79 on Wednesday. The firm has a market capitalization of $8.94 billion and a price-to-earnings ratio of 30.69. The firm’s 50-day moving average is $21.19 and its 200-day moving average is $18.62. Orion Corp has a 12-month low of $18.92 and a 12-month high of $31.79.

TRADEMARK VIOLATION NOTICE: This article was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.watchlistnews.com/orion-corp-oriny-rating-lowered-to-hold-at-zacks-investment-research/1492881.html.

Get a free copy of the Zacks research report on Orion Corp (ORINY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Orion Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.